Privo Technologies, Inc. specializes in biopharmaceutical innovations, focusing on advanced biotechnology solutions and life sciences. The company aims to develop cutting-edge therapies and enhance healthcare outcomes through its research and development efforts, contributing significantly to the biotechnology and pharmaceuticals sectors.
Specialties
Targeted cancer therapies
Innovative biopharmaceuticals
Locoregional cancer treatments
Advanced drug delivery systems
Research in oncology solutions
Products & Services
Targeted cancer therapies
Topical and injectable formulations
Hydrogels and patches
Locoregional cancer treatments
Compounds for other indications
Contact Information
No contact information available
Competitors & Similar Companies(10)
Amgen Inc.
Gilead Sciences, Inc.
Biogen Inc.
Regeneron Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated
Eli Lilly and Company
Roche Holding AG
Novartis AG
Thermo Fisher Scientific Inc.
Moderna, Inc.
News & Media
Search Terms:
privo technologies
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Privo Technologies
Where is Privo Technologies located?
The headquarter of Privo Technologies is located in Peabody, Massachusetts, United States
What is the official website of Privo Technologies?
Privo Technologies belongs to the Biotechnology, Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of Privo Technologies?
Privo Technologies specializes in Targeted cancer therapies, Innovative biopharmaceuticals, Locoregional cancer treatments, Advanced drug delivery systems, Research in oncology solutions.
What products and services is Privo Technologies likely to offer?
Privo Technologies offers Targeted cancer therapies, Topical and injectable formulations, Hydrogels and patches, Locoregional cancer treatments, Compounds for other indications.
Who are the competitors of Privo Technologies?
Competitors of Privo Technologies are Amgen Inc., Gilead Sciences, Inc., Biogen Inc., Regeneron Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated, Eli Lilly and Company, Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Moderna, Inc..
What does Privo Technologies do?
Privo Technologies, Inc. specializes in biopharmaceutical innovations, focusing on advanced biotechnology solutions and life sciences. The company aims to develop cutting-edge therapies and enhance healthcare outcomes through its research and development efforts, contributing significantly to the biotechnology and pharmaceuticals sectors.
What are the social media links of Privo Technologies?